Skip to main content
. 2022 Sep 9;8(3):20552173221124023. doi: 10.1177/20552173221124023

Figure 1.

Figure 1.

Patient populations, study period and service evaluation period. PMS included patients with primary or secondary PMS and relapsing secondary PMS.

DMT: disease-modifying therapy; PMS: progressive MS; RMS: relapsing MS.